Cargando…

Costs of clinical events in type 2 diabetes mellitus patients in the Netherlands: A systematic review

BACKGROUND: Type 2 diabetes mellitus (T2DM) is an established risk factor for cardiovascular and nephropathic events. In the Netherlands, prevalence of T2DM is expected to be as high as 8% by 2025. This will result in significant clinical and economic impact, highlighting the need for well-informed...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Schoonhoven, Alexander V., Gout-Zwart, Judith J., de Vries, Marijke J. S., van Asselt, Antoinette D. I., Dvortsin, Evgeni, Vemer, Pepijn, van Boven, Job F. M., Postma, Maarten J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730996/ https://www.ncbi.nlm.nih.gov/pubmed/31490989 http://dx.doi.org/10.1371/journal.pone.0221856

Ejemplares similares

Comparative Cost-Effectiveness of Drugs in Early versus Late Stages of Cancer; Review of the Literature and a Case Study in Breast Cancer
por: Dvortsin, Evgeni, et al.
Publicado: (2016)

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)

Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review
por: Fitria, Najmiatul, et al.
Publicado: (2018)

Rotavirus Vaccination of Infants Delayed and Limited within the National Immunization Programme in the Netherlands: An Opportunity Lost
por: Zeevat, Florian, et al.
Publicado: (2021)

Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
por: Gout-Zwart, Judith J., et al.
Publicado: (2019)

Economic Burden in Chinese Patients with Diabetes Mellitus Using Electronic Insurance Claims Data
por: Huang, Yunyu, et al.
Publicado: (2016)

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
por: van Asselt, Thea, et al.
Publicado: (2017)

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
por: de Jong, Lisa A., et al.
Publicado: (2018)

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands
por: Stevanović, J., et al.
Publicado: (2016)

Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands
por: Quist, Sara W., et al.
Publicado: (2023)

Modelling the Cost-Effectiveness of Implementing a Dietary Intervention in Renal Transplant Recipients
por: Coerts, Friso B., et al.
Publicado: (2021)

A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy
por: Berm, Elizabeth J. J., et al.
Publicado: (2016)

Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review
por: Zakiyah, Neily, et al.
Publicado: (2016)

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups
por: Al Khayat, Mohamed N. M. T., et al.
Publicado: (2022)

The Cost-Effectiveness of Hepatitis C Virus Screening Strategies among Recently Arrived Migrants in the Netherlands
por: Al Khayat, Mohamed N.M.T., et al.
Publicado: (2020)

Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments
por: Zakiyah, Neily, et al.
Publicado: (2015)

Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations
por: Gout-Zwart, Judith J., et al.
Publicado: (2018)

Burden of early, advanced and metastatic breast cancer in The Netherlands
por: Vondeling, G. T., et al.
Publicado: (2018)

Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
por: Lugnér, Anna K, et al.
Publicado: (2012)

Early cost-effectiveness analysis of screening for preeclampsia in nulliparous women: A modelling approach in European high-income settings
por: Zakiyah, Neily, et al.
Publicado: (2022)

Mental health economics: the Netherlands experience
por: Murphy, Aileen, et al.
Publicado: (2020)

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
por: Westerink, Lotte, et al.
Publicado: (2022)

Medication Monitoring and Optimization: A Targeted Pharmacist Program for Effective and Cost-Effective Improvement of Chronic Therapy Adherence
por: van Boven, Job F.M., et al.
Publicado: (2014)

Multidisciplinary tuberculosis care: leveraging the role of hospital pharmacists
por: Iskandar, Deni, et al.
Publicado: (2023)

Diabetes distress in Indonesian patients with type 2 diabetes: a comparison between primary and tertiary care
por: Arifin, Bustanul, et al.
Publicado: (2019)

Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review
por: van der Pol, Simon, et al.
Publicado: (2021)

Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting
por: van der Pol, Simon, et al.
Publicado: (2021)

Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital
por: Dik, Jan-Willem H., et al.
Publicado: (2016)

Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol
por: van Boven, Job F M, et al.
Publicado: (2015)

P4 Cost Analysis of Post-COVID-19 Healthcare Consumption in the Netherlands
por: Fens, T, et al.
Publicado: (2022)

Value judgment of new medical treatments: Societal and patient perspectives to inform priority setting in The Netherlands
por: Nicolet, Anna, et al.
Publicado: (2020)

Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D
por: Arifin, Bustanul, et al.
Publicado: (2019)

Improving Adherence to Lipid-Lowering Therapy in a Community Pharmacy Intervention Program: A Cost-Effectiveness Analysis
por: Vegter, Stefan, et al.
Publicado: (2014)

Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis
por: van Boven, Job FM, et al.
Publicado: (2014)

Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?
por: Urbanus, Anouk T., et al.
Publicado: (2013)

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
por: Eijsink, Job F. H., et al.
Publicado: (2020)

Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor
por: Vemer, Pepijn, et al.
Publicado: (2010)

Prevalence and Economic Burden of Respiratory Diseases in Central Asia and Russia: A Systematic Review
por: Tabyshova, Aizhamal, et al.
Publicado: (2020)

Meningococcal Serogroup A, C, W(135) and Y Conjugated Vaccine: A Cost-Effectiveness Analysis in the Netherlands
por: Hepkema, Hiltsje, et al.
Publicado: (2013)

Financial evaluations of antibiotic stewardship programs—a systematic review
por: Dik, Jan-Willem H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kqr5nifrg0rfosvre9192o53el